The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients | Zendy

Lama Faddoul | Zendy; Bahia Chahine | Zendy; Sahar Haydar | Zendy; Sahar Abourida | Zendy; Souheil Hallit | Zendy; Etwal Bou Raad | Zendy

Open Access

The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients

Author(s) -

Lama Faddoul,

Bahia Chahine,

Sahar Haydar,

Sahar Abourida,

Souheil Hallit,

Etwal Bou Raad

Publication year - 2018

Publication title -

pharmacy practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 24

eISSN - 1886-3655

pISSN - 1885-642X

DOI - 10.18549/pharmpract.2018.04.1220

Subject(s) - pramipexole , parkinson's disease , medicine , levodopa , entacapone , carbidopa , gastroenterology , disease

This study demonstrated the efficacy of Pramipexole ER on decreasing the total levodopa equivalent dose (LED).The role of health care professionals is to maintain the patient on the lowest effective levodopa equivalent daily dose and optimize the treatment therapy, thus decreasing the side effects that might arise from overdosing of antiparkinsonian drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research